WHO issues first guidance on using GLP-1 drugs to treat obesity
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.
Dec 2, 2025
0
0
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.
Dec 2, 2025
0
0
Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, ...
Dec 2, 2025
0
15
Between Halloween candy, Thanksgiving pies and holiday cookies, the end of the year is often packed with opportunities to consume sugar. But what happens in your mouth during those first minutes and hours after eating those ...
Dec 2, 2025
0
0
Eating disorders in moms-to-be are linked to a heightened risk of asthma and wheezing in their children, irrespective of the type of disorder, presence of co-existing depression/anxiety, or the timing of their child's exposure, ...
Dec 2, 2025
0
0
Over-reliance on generative AI risks eroding new and future doctors' critical thinking skills, while potentially reinforcing existing data bias and inequity, warns an editorial published in the online journal BMJ Evidence ...
Dec 2, 2025
0
0
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis published in JCI Insight.
Dec 2, 2025
0
0
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, according to new research from the Valente lab at The Herbert ...
Dec 2, 2025
0
0
Between 0.7% and 1.5% of people in developed countries are estimated to suffer from intellectual disability (ID). In Spain, this is equivalent to more than 400,000 people. The term intellectual disability refers to a set ...
Dec 2, 2025
0
0
Sweat contains a wealth of biological information that, with the help of artificial intelligence and next-generation sensors, could transform how we monitor our health and well-being, a new study suggests.
Dec 2, 2025
0
0
Researchers at Children's Hospital of Philadelphia (CHOP) identified a potential new therapeutic target for eosinophilic esophagitis (EoE), a chronic allergic inflammatory disease of the esophagus. The findings were published ...
Dec 2, 2025
0
0